The present invention provides DNA encoding an FcRIII(CDl6) receptor protein
expressed on NK cells. The invention also provides a stable cell line expressing
the FcRIII(CDl6) from NK cells. Further provided is a method for determining
the presence of HIV-enhancing antibodies and a method for treating an HIV-infected subject.